Advisorshares Vice ETF (ACT)
$25.74 0.04 (0.14%)
16:14 EST ACT Stock Quote Delayed 15 Minutes
Previous Close $25.71
Market Cap -
PE Ratio -
Volume (Avg. Vol.) 1,340
Day's Range 25.74 - 25.84
52-Week Range 22.22 - 26.02
Dividend & Yield 0.05 (0.17%)
ACT Stock Predictions, Articles, and Advisorshares Vice ETF News
- From InvestorPlace
- From the Web
Choosing the best ETF in 2020 won't be easy, but many of these funds stand a chance at being among the best ETFs to buy for next year.
The ACT ETF has long-term durability with concentrated exposure to select companies related to alcohol, cannabis and tobacco.
Marijuana stocks could be great long-term investments. However, they are still a risky bet. These marijuana ETFs make owning them a little less dangerous.
The current crop of vice ETFs include more focused plays, such as funds focusing explicitly on specific vices. For example, today's vice ETFs include a marijuana fund, a gambling ETF and so on.
The universe of U.S. marijuana ETFs is sparsely populated. Right now, these marijuana ETFs are the only two that U.S. investors need consider.
Marijuana ETFs may still be few and far between, but these three are more than enough to get regular investors safely into the game.
In the world of ETFs, the most widely anticipated products are those related to cryptocurrencies and marijuana stocks. Investors will be waiting awhile for digital currency ETFs as regulators recently rebuffed plans for such funds. Fortunately, marijuana ETFs are not encountering the same resistance.
Some of the best ETFs to buy focus either on the light or dark sides of the market. Here's what investors should know about ETFs that focus on socially responsible stocks and sin stocks.
Healthcare stocks remained flat on Thursday morning on Wall Street.
Healthcare stocks rose broadly on Wall Street today, with the sector seeing an overall increase of 1.2%.
Healthcare stocks finished flat on Thursday on Wall Street.
A new batch of 13Fs has given us insight into what Wall Street's "smart money" thought was worth buying and selling in Q1. Here are some of the best ideas from the group.
Healthcare stocks rose 0.2% on Wall Street so far on Monday.
Healthcare stocks finished up 0.6% on Wall Street on Monday.
By Jeff Reeves
After some recent consolidation, biotech stocks could be a buy now that the worst of the washout is over and sentiment is improving.
Healthcare stocks finished up 0.2% on Wall Street on Tuesday.
From Seeking Alpha